Literature DB >> 20090406

Expression and induction of cytochrome p450 isoenzymes in human skin equivalents.

M M Neis1, A Wendel, T Wiederholt, Y Marquardt, S Joussen, J M Baron, H F Merk.   

Abstract

Organotypic skin models are frequently used for a wide range of applications and latterly also for dermatotoxicological studies. To evaluate their practicability for the investigation of xenobiotic metabolism in human skin we compared three types of organotypic skin models, acquired by purchase from different manufacturers, to a self-constructed in-house model with regard to cytochrome P450 (CYP) isoenzyme expression on mRNA and protein level and the inducibility of these enzymes by aryl hydrocarbon receptor ligands. To induce enzyme activity, models were treated with benzanthracene, liquor carbonis detergens, pix lithanthracis or dimethyl sulfoxide as a solvent control. RNA was isolated by phenol-chloroform extraction and purified. Gene expression patterns were studied by cDNA microarray analysis. Microarray data were confirmed by real-time PCR. For quality control of the models and to detect and localize enzyme expression, immunofluorescence staining was performed with antibodies against CYPs and structure proteins. The immunofluorescence staining demonstrated the regular structure of our models. We could provide evidence for the expression of CYP types 1A1, 1B1, 2E1, 2C and 3A5 in organotypic skin models. The expression of CYP1A1 and CYP1B1 was highly inducible by treatment with liquor carbonis detergens. The proof of the expression and inducibility of CYP enzymes in organotypic skin models suggests that skin equivalents are a valuable tool that can emulate CYP-dependent metabolism of drugs and other xenobiotics in human skin. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20090406     DOI: 10.1159/000257261

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  14 in total

1.  Effects of non-ablative fractional erbium glass laser treatment on gene regulation in human three-dimensional skin models.

Authors:  Philipp M Amann; Yvonne Marquardt; Timm Steiner; Frank Hölzle; Claudia Skazik-Voogt; Ruth Heise; Jens M Baron
Journal:  Lasers Med Sci       Date:  2016-01-21       Impact factor: 3.161

2.  Molecular effects of fractional ablative erbium:YAG laser treatment with multiple stacked pulses on standardized human three-dimensional organotypic skin models.

Authors:  Laurenz Schmitt; P M Amann; Y Marquardt; R Heise; K Czaja; P A Gerber; T Steiner; F Hölzle; Jens Malte Baron
Journal:  Lasers Med Sci       Date:  2017-03-15       Impact factor: 3.161

Review 3.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

4.  The effects of constant flow bioreactor cultivation and keratinocyte seeding densities on prevascularized organotypic skin grafts based on a fibrin scaffold.

Authors:  Marius Julian Helmedag; Stefan Weinandy; Yvonne Marquardt; Jens Malte Baron; Norbert Pallua; Christoph V Suschek; Stefan Jockenhoevel
Journal:  Tissue Eng Part A       Date:  2014-11-20       Impact factor: 3.845

5.  Direct biological effects of fractional ultrapulsed CO2 laser irradiation on keratinocytes and fibroblasts in human organotypic full-thickness 3D skin models.

Authors:  L Schmitt; S Huth; P M Amann; Y Marquardt; R Heise; K Fietkau; L Huth; T Steiner; F Hölzle; J M Baron
Journal:  Lasers Med Sci       Date:  2017-12-07       Impact factor: 3.161

Review 6.  Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; K Guth; R Landsiedel
Journal:  Arch Toxicol       Date:  2014-11-05       Impact factor: 5.153

7.  Downregulation of STRA6 expression in epidermal keratinocytes leads to hyperproliferation-associated differentiation in both in vitro and in vivo skin models.

Authors:  Claudia Skazik; Philipp M Amann; Ruth Heise; Yvonne Marquardt; Katharina Czaja; Arianna Kim; Ralph Rühl; Peter Kurschat; Hans F Merk; David R Bickers; Jens M Baron
Journal:  J Invest Dermatol       Date:  2013-11-27       Impact factor: 8.551

8.  Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy.

Authors:  Massimo Mammucari; Antonio Gatti; Sergio Maggiori; Alessandro F Sabato
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-13       Impact factor: 2.629

9.  Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.

Authors:  Tania Brocks; Oleg Fedorchenko; Nicola Schliermann; Astrid Stein; Ute M Moll; Seth Seegobin; Manfred Dewor; Michael Hallek; Yvonne Marquardt; Katharina Fietkau; Ruth Heise; Sebastian Huth; Herbert Pfister; Juergen Bernhagen; Richard Bucala; Jens M Baron; Guenter Fingerle-Rowson
Journal:  FASEB J       Date:  2016-10-19       Impact factor: 5.834

10.  The oncogenic FIP1L1-PDGFRα fusion protein displays skewed signaling properties compared to its wild-type PDGFRα counterpart.

Authors:  Serge Haan; Christelle Bahlawane; Jiali Wang; Petr V Nazarov; Arnaud Muller; René Eulenfeld; Claude Haan; Catherine Rolvering; Laurent Vallar; Venkata P Satagopam; Thomas Sauter; Monique Yvonne Wiesinger
Journal:  JAKSTAT       Date:  2015-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.